The summary below is from the full report titled “Subcutaneous Enoxaparin Once or Twice Daily Compared with Intravenous Unfractionated Heparin for Treatment of Venous Thromboembolic Disease.” It is in the 6 February 2001 issue of Annals of Internal Medicine (volume 134, pages 191-202). The authors are G Merli, TE Spiro, C-G Olsson, U Abildgaard, BL Davidson, A Eldor, D Elias, A Grigg, D Musset, GM Rodgers, AA Trowbridge, RD Yusen, and K Zawilska, for the Enoxaparin Clinical Trial Group.
Comparison of Two Forms of the Anticlotting Drug Heparin for Treatment of Blood Clots in the Legs. Ann Intern Med. 2001;134:I–76. doi: 10.7326/0003-4819-134-3-200102060-00005
Download citation file:
Published: Ann Intern Med. 2001;134(3):I-76.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use